Instituto do Cancer Arnaldo Vieira de Carvalho

São Paulo, São Paulo 01224-010

0 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non-small-cell Lung, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Non Small Cell Lung Carcinoma, Solid Tumors

Studies at this site

• Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early
• A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Stopped early
• OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed